Rakhi Kumar - Mar 30, 2022 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Chief Accounting Officer
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Rakhi Kumar
Stock symbol
ROIV
Transactions as of
Mar 30, 2022
Transactions value $
-$21,877
Form type
4
Date filed
4/1/2022, 06:00 PM
Previous filing
Mar 29, 2022
Next filing
Apr 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Sale -$12K -2.49K -1.51% $4.84 163K Mar 30, 2022 Direct F1, F2
transaction ROIV Common Shares Tax liability -$9.84K -2.08K -1.28% $4.74 160K Mar 30, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person.
F2 The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
F3 Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.